Antihypertensive drug induced gingival hyperplasia is usually referred to as drug gingival hyperplasia, refers to the long-term use of calcium channel blockers class of antihypertensive drugs, such as nifedipine, nimodipine and so on caused by the fibrous gingival hyperplasia and volume increase. Mainly in the interdental papillae or gingival margin hyperplasia hypertrophy, bulbous, mulberry-like or lobular, light pink, solid and slightly elastic texture, severe impediment to chewing. It is common in the anterior region, but can also occur in the whole mouth, usually painless, and can be accompanied by bad breath, bleeding from brushing and periodontal pus, and other symptoms of severe gingivitis. The condition can be aggravated by extrusion of hyperplastic gingiva, loosening and displacement of teeth, poor oral hygiene, trauma and dental caries, poor fillings and orthodontic appliances. Gingival hyperplasia is one of the side effects of the calcium channel blocker class of antihypertensive drugs, and in severe cases a change in medication may be considered.